General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boeringer-Ingelheim(MODEST), Akcea (MODEST), AstraZeneca Pharmaceuticals(MODEST), Novo Nordisk Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Roche Diagnostics(MODEST), Takeda Pharmaceuticals North America, Inc(MODEST), BMS-Pfizer(MODEST), Johnson & Johnson(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Amgen Inc.(SIGNIFICANT), CHFS(MODEST)

View Full Disclosure